| Universe Pharmaceuticals INC |
UPC |
0% | 0% |
| Connect Biopharma Holdings Ltd. |
CNTB |
-20% | 19% |
| Gain Therapeutics Inc. |
GANX |
12% | -34% |
| Prometheus Biosciences Inc. |
RXDX |
0% | 0% |
| NexImmune Inc. |
NEXI |
0% | 0% |
| Adagene Inc. |
ADAG |
2% | 4% |
| Angion Biomedica Corp. |
ANGN |
0% | 0% |
| Bolt Biotherapeutics Inc. |
BOLT |
10% | -52% |
| Pharvaris B.V. |
PHVS |
-4% | -31% |
| Terns Pharmaceuticals Inc. |
TERN |
4% | -15% |
| Vor Biopharma Inc. |
VOR |
20% | -51% |
| Landos Biopharma Inc. |
LABP |
0% | 0% |
| Sana Biotechnology Inc. |
SANA |
4% | -60% |
| Sensei Biotherapeutics Inc. |
SNSE |
3% | -29% |
| Gracell Biotechnologies Inc. |
GRCL |
0% | 2% |
| Virios Therapeutics LLC |
VIRI |
0% | -68% |
| AbCellera Biologics Inc. |
ABCL |
6% | -49% |
| Olema Pharmaceuticals Inc. |
OLMA |
1% | -58% |
| Atea Pharmaceuticals Inc. |
AVIR |
4% | 10% |
| Galecto Inc. |
GLTO |
0% | -39% |
|
|
|
|
| Foghorn Therapeutics Inc. |
FHTX |
1% | -27% |
| Nkarta Inc. |
NKTX |
0% | -62% |
| Zomedica Pharmaceuticals Corp |
ZOM |
21% | 0% |
| Synthetic Biologics Inc |
SYN |
0% | 0% |
| Palatin Technologies Inc |
PTN |
26% | 0% |
| Oragenics Inc |
OGEN |
0% | 0% |
| NovaBay Pharmaceuticals Inc |
NBY |
0% | 0% |
| Matinas Biopharma Holdings Inc |
MTNB |
0% | 0% |
| iBio Inc |
IBIO |
0% | 0% |
| CorMedix Inc |
CRMD |
1% | 115% |
| China Pharma Holdings Inc |
CPHI |
0% | 0% |
| Can Fite Biopharma Ltd |
CANF |
0% | 0% |
| Ampio Pharmaceuticals Inc |
AMPE |
0% | 0% |
| Actinium Pharmaceuticals Inc |
ATNM |
14% | 0% |
| Zoetis Inc |
ZTS |
0% | -17% |
| Teva Pharmaceutical Industries Limited |
TEVA |
-4% | 111% |
| Sanofi |
SNY |
-0% | -3% |
| Prestige Consumer Healthcare Inc |
PBH |
-2% | 27% |
| Pfizer Inc |
PFE |
0% | -8% |
| Perrigo Company |
PRGO |
1% | -20% |
|
|
|
|
| Novo Nordisk A S |
NVO |
2% | -17% |
| Novartis AG |
NVS |
0% | -4% |
| Merck & Company Inc |
MRK |
-0% | -9% |
| Lannett Co Inc |
LCI |
0% | 0% |
| Johnson & Johnson |
JNJ |
-0% | -8% |
| GlaxoSmithKline PLC |
GSK |
-1% | -9% |
| Emergent Biosolutions Inc |
EBS |
8% | 298% |
| Eli Lilly and Company |
LLY |
1% | 32% |
| Dr Reddy`s Laboratories Ltd |
RDY |
-2% | -77% |
| Bristol Myers Squibb Company |
BMY |
-0% | 10% |
| Bausch Health Companies Inc |
BHC |
-3% | 0% |
| Astrazeneca PLC |
AZN |
1% | -3% |
| AbbVie Inc |
ABBV |
2% | 15% |
| Abbott Laboratories |
ABT |
1% | 3% |
| Zealand Pharma A S |
ZEAL |
0% | 0% |
| XTL Biopharmaceuticals Ltd |
XTLB |
9% | 101% |
| XOMA Corporation |
XOMA |
3% | 40% |
| Xenetic Biosciences Inc |
XBIO |
0% | 0% |
| Xencor Inc |
XNCR |
5% | 8% |
| VistaGen Therapeutics Inc |
VTGN |
0% | 0% |
|
|
|
|
| Veru Inc |
VERU |
12% | -9% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
1% | -1% |
| Verona Pharma plc |
VRNA |
0% | 134% |
| Verastem Inc |
VSTM |
0% | 0% |
| United Therapeutics Corporation |
UTHR |
1% | 60% |
| Tyme Technologies Inc |
TYME |
0% | 0% |
| Tonix Pharmaceuticals Holding Corp |
TNXP |
0% | 0% |
| Tiziana Life Sciences plc |
TLSA |
4% | 25% |
| Theravance Biopharma Inc |
TBPH |
-1% | -16% |
| TherapeuticsMD Inc |
TXMD |
87% | -65% |
| TG Therapeutics Inc |
TGTX |
-0% | 76% |
| Supernus Pharmaceuticals Inc |
SUPN |
2% | 25% |
| Spectrum Pharmaceuticals Inc |
SPPI |
0% | 0% |
| Sonoma Pharmaceuticals Inc |
SNOA |
0% | -11% |
| Soligenix Inc |
SNGX |
0% | 0% |
| Sinovac Biotech Ltd |
SVA |
0% | 0% |
| SIGA Technologies Inc |
SIGA |
5% | 8% |
| Sesen Bio Inc |
SESN |
0% | 0% |
| SELLAS Life Sciences Group Inc |
SLS |
2% | -2% |
| Savara Inc |
SVRA |
1% | -34% |
|
|
|
|
| Sarepta Therapeutics Inc |
SRPT |
4% | 26% |
| Rocket Pharmaceuticals Inc |
RCKT |
-0% | -58% |
| Rigel Pharmaceuticals Inc |
RIGL |
0% | -46% |
| Reliv` International Inc |
RELV |
0% | 0% |
| Regulus Therapeutics Inc |
RGLS |
1% | 24% |
| Regeneron Pharmaceuticals Inc |
REGN |
1% | -19% |
| Redhill Biopharma Ltd |
RDHL |
0% | 0% |
| Puma Biotechnology Inc |
PBYI |
-3% | -30% |
| Pulmatrix Inc |
PULM |
3% | 275% |
| PTC Therapeutics Inc |
PTCT |
3% | 64% |
| Prothena Corporation plc |
PRTA |
0% | -62% |
| ProPhase Labs Inc |
PRPH |
7% | -83% |
| PLx Pharma Inc |
PLXP |
0% | 0% |
| Phio Pharmaceuticals Corp |
PHIO |
0% | 0% |
| Paratek Pharmaceuticals Inc |
PRTK |
0% | 0% |
| Pacira Pharmaceuticals Inc |
PCRX |
-2% | -44% |
| Orgenesis Inc |
ORGS |
0% | 36% |
| Organogenesis Holdings Inc |
ORGO |
-3% | -22% |
| Oramed Pharmaceuticals Inc |
ORMP |
1% | 5% |
| Opko Health Inc |
OPK |
0% | -3% |
|
|
|
|
| OncoSec Medical Incorporated |
ONCS |
0% | 0% |
| Onconova Therapeutics Inc |
ONTX |
0% | -54% |
| Oncolytics Biotech Inc |
ONCY |
6% | -33% |
| Omeros Corporation |
OMER |
13% | 202% |
| Neptune Wellness Solutions Inc |
NEPT |
0% | 0% |
| Nektar Therapeutics |
NKTR |
20% | 65% |
| Nature`s Sunshine Products Inc |
NATR |
0% | -16% |
| Mustang Bio Inc |
MBIO |
0% | 0% |
| Molecular Templates Inc |
MTEM |
0% | 0% |
| Mirati Therapeutics Inc |
MRTX |
0% | -0% |
| Midatech Pharma PLC |
MTP |
0% | 0% |
| Merrimack Pharmaceuticals Inc |
MACK |
0% | 10% |
| MEI Pharma Inc |
MEIP |
0% | 0% |
| MediciNova Inc |
MNOV |
0% | 42% |
| Marker Therapeutics Inc |
MRKR |
0% | 0% |
| MannKind Corporation |
MNKD |
1% | 77% |
| Madrigal Pharmaceuticals Inc |
MDGL |
4% | 33% |
| MacroGenics Inc |
MGNX |
6% | -66% |
| Lipocine Inc |
LPCN |
0% | 0% |
| Ligand Pharmaceuticals Incorporated |
LGND |
3% | 49% |
|
|
|
|
| Lifevantage Corporation |
LFVN |
1% | 194% |
| Lexicon Pharmaceuticals Inc |
LXRX |
7% | -52% |
| LEAP THERAPEUTICS INC |
LPTX |
0% | 0% |
| Karyopharm Therapeutics Inc |
KPTI |
18% | -24% |
| Kamada Ltd |
KMDA |
7% | -1% |
| KalVista Pharmaceuticals Inc |
KALV |
6% | -31% |
| Jazz Pharmaceuticals plc |
JAZZ |
-1% | 0% |
| Ironwood Pharmaceuticals Inc |
IRWD |
2% | -61% |
| Ionis Pharmaceuticals Inc |
IONS |
-0% | -31% |
| Intra Cellular Therapies Inc |
ITCI |
0% | 17% |
| Intercept Pharmaceuticals Inc |
ICPT |
0% | 0% |
| Insmed Inc |
INSM |
1% | 123% |
| Innoviva Inc |
INVA |
1% | 8% |
| Infinity Pharmaceuticals Inc |
INFI |
0% | 0% |
| IMV Inc |
IMV |
0% | 0% |
| Immutep Limited |
IMMP |
1% | -10% |
| Immuron Limited |
IMRN |
3% | -10% |
| ImmunoGen Inc |
IMGN |
0% | 5% |
| Horizon Pharma plc |
HZNP |
0% | 0% |
| Heron Therapeutics Inc |
HRTX |
9% | -10% |
|
|
|
|
| Grifols S A |
GRFS |
4% | -36% |
| Geron Corporation |
GERN |
0% | 68% |
| Galectin Therapeutics Inc |
GALT |
-11% | -21% |
| Fortress Biotech Inc |
FBIOP |
11% | -48% |
| Fortress Biotech Inc |
FBIO |
0% | 0% |
| Evoke Pharma Inc |
EVOK |
0% | -51% |
| Evofem Biosciences Inc |
EVFM |
0% | 0% |
| ESSA Pharma Inc |
EPIX |
4% | -73% |
| Esperion Therapeutics Inc |
ESPR |
-1% | -26% |
| Epizyme Inc |
EPZM |
0% | 0% |
| Enochian Biosciences Inc |
ENOB |
10% | -73% |
| Endo International plc |
ENDP |
0% | 0% |
| Enanta Pharmaceuticals Inc |
ENTA |
-3% | -39% |
| Dynavax Technologies Corporation |
DVAX |
1% | -9% |
| DURECT Corporation |
DRRX |
11% | 27% |
| Diffusion Pharmaceuticals Inc |
DFFN |
0% | 0% |
| DiaMedica Therapeutics Inc |
DMAC |
3% | 91% |
| Dare Bioscience Inc |
DARE |
0% | 18% |
| Cytokinetics Incorporated |
CYTK |
5% | -44% |
| CymaBay Therapeutics Inc |
CBAY |
0% | 38% |
|
|
|
|
| Cyclacel Pharmaceuticals Inc |
CYCCP |
18% | -55% |
| Cyclacel Pharmaceuticals Inc |
CYCC |
0% | 0% |
| Cumberland Pharmaceuticals Inc |
CPIX |
-6% | 40% |
| CTI BioPharma Corp |
CTIC |
0% | 0% |
| Corcept Therapeutics Incorporated |
CORT |
1% | 55% |
| Corbus Pharmaceuticals Holdings Inc |
CRBP |
0% | 0% |
| ContraFect Corporation |
CFRX |
0% | 0% |
| CohBar Inc |
CWBR |
0% | 0% |
| Cocrystal Pharma Inc |
COCP |
17% | 19% |
| Clovis Oncology Inc |
CLVS |
0% | 0% |
| Citius Pharmaceuticals Inc |
CTXRW |
0% | 0% |
| Citius Pharmaceuticals Inc |
CTXR |
0% | -26% |
| Chimerix Inc |
CMRX |
5% | 259% |
| ChemoCentryx Inc |
CCXI |
0% | 0% |
| Chembio Diagnostics Inc |
CEMI |
0% | 0% |
| Checkpoint Therapeutics Inc |
CKPT |
14% | 39% |
| Centrexion Therapeutics Corporation |
CNTX |
0% | 0% |
| Celsion Corporation |
CLSN |
0% | 0% |
| Cellectar Biosciences Inc |
CLRB |
16% | -89% |
| Catalyst Pharmaceuticals Inc |
CPRX |
2% | 24% |
|
|
|
|
| Catalyst Biosciences Inc |
CBIO |
0% | 0% |
| Capricor Therapeutics Inc |
CAPR |
13% | 182% |
| Bison Capital Acquisition Corp |
BCACU |
0% | 0% |
| Bison Capital Acquisition Corp |
BCAC |
0% | 0% |
| Bio Path Holdings Inc |
BPTH |
0% | -21% |
| BioMarin Pharmaceutical Inc |
BMRN |
2% | -32% |
| BioLineRx Ltd |
BLRX |
27% | -87% |
| Aytu BioScience Inc |
AYTU |
0% | 0% |
| Avid Bioservices Inc |
CDMO |
-0% | 90% |
| AVEO Pharmaceuticals Inc |
AVEO |
0% | 0% |
| Avadel Pharmaceuticals plc |
AVDL |
0% | 16% |
| Aurinia Pharmaceuticals Inc |
AUPH |
-5% | -0% |
| Atossa Genetics Inc |
ATOS |
7% | 7% |
| Athersys Inc |
ATHX |
0% | 0% |
| Assertio Therapeutics Inc |
ASRT |
1% | -19% |
| Assembly Biosciences Inc |
ASMB |
0% | 23% |
| Arrowhead Pharmaceuticals Inc |
ARWR |
5% | -39% |
| Array BioPharma Inc |
ARRY |
11% | -64% |
| Arbutus Biopharma Corporation |
ABUS |
4% | 31% |
| Aptevo Therapeutics Inc |
APVO |
0% | -29% |
|
|
|
|
| Apellis Pharmaceuticals Inc |
APLS |
5% | -47% |
| ANI Pharmaceuticals Inc |
ANIP |
0% | 0% |
| Amicus Therapeutics Inc |
FOLD |
0% | -34% |
| Amarin Corporation plc |
AMRN |
9% | -44% |
| Altimmune Inc |
ALT |
1% | -36% |
| Alpine Immune Sciences Inc |
ALPN |
0% | 239% |
| Alnylam Pharmaceuticals Inc |
ALNY |
-0% | 23% |
| Alkermes plc |
ALKS |
1% | 4% |
| Alimera Sciences Inc |
ALIM |
0% | 28% |
| Albireo Pharma Inc |
ALBO |
0% | 0% |
| Akari Therapeutics Plc |
AKTX |
0% | 0% |
| Agios Pharmaceuticals Inc |
AGIO |
-2% | 48% |
| AEterna Zentaris Inc |
AEZS |
0% | 5% |
| Advaxis Inc |
ADXS |
0% | 0% |
| Adamis Pharmaceuticals Corporation |
ADMP |
0% | 0% |
| Achillion Pharmaceuticals Inc |
ACHN |
0% | 0% |
| Acer Therapeutics Inc |
ACER |
0% | 0% |
| AcelRx Pharmaceuticals Inc |
ACRX |
15% | -27% |
| Acasti Pharma Inc |
ACST |
0% | 0% |
| ACADIA Pharmaceuticals Inc |
ACAD |
0% | -41% |
|
|
|
|
| Cue Biopharma Inc. |
CUE |
29% | -59% |
| Eyenovia Inc. |
EYEN |
-27% | -93% |
| Sol-Gel Technologies Ltd. |
SLGL |
8% | -14% |
| Evolus Inc. |
EOLS |
4% | 5% |
| BioXcel Therapeutics Inc. |
BTAI |
7% | -87% |
| Arcus Biosciences Inc. |
RCUS |
1% | -22% |
| Homology Medicines Inc. |
FIXX |
0% | 55% |
| Genprex Inc. |
GNPX |
0% | -20% |
| MorphoSys AG |
MOR |
0% | 83% |
| Unity Biotechnology Inc. |
UBX |
29% | -49% |
| ASLAN Pharmaceuticals Limited |
ASLN |
0% | 0% |
| Evelo Biosciences Inc. |
EVLO |
0% | 0% |
| Kiniksa Pharmaceuticals Ltd. |
KNSA |
0% | 6% |
| Iterum Therapeutics plc |
ITRM |
9% | -10% |
| Verrica Pharmaceuticals Inc. |
VRCA |
0% | -90% |
| Xeris Pharmaceuticals Inc. |
XERS |
7% | 44% |
| Aptinyx Inc. |
APTX |
0% | 0% |
| Kezar Life Sciences Inc. |
KZR |
0% | -37% |
| Magenta Therapeutics Inc. |
MGTA |
0% | 0% |
| Tricida Inc. |
TCDA |
0% | 0% |
|
|
|
|
| Crinetics Pharmaceuticals Inc. |
CRNX |
4% | 44% |
| Allakos Inc. |
ALLK |
-4% | -56% |
| Provention Bio Inc. |
PRVB |
0% | 0% |
| Aquestive Therapeutics Inc. |
AQST |
0% | 76% |
| Adial Pharmaceuticals Inc |
ADIL |
0% | 0% |
| Vaccinex Inc. |
VCNX |
0% | 0% |
| Aridis Pharmaceuticals Inc. |
ARDS |
0% | 0% |
| Elanco Animal Health Incorporated |
ELAN |
-1% | -19% |
| Y-mAbs Therapeutics Inc. |
YMAB |
4% | 15% |
| Entasis Therapeutics Holdings Inc. |
ETTX |
0% | 0% |
| Arvinas Inc. |
ARVN |
7% | -53% |
| Equillium Inc. |
EQ |
4% | 2% |
| PhaseBio Pharmaceuticals Inc. |
PHAS |
0% | 0% |
| Eton Pharmaceutcials Inc. |
ETON |
-2% | 204% |
| ObsEva SA |
OBSV |
0% | 0% |
| AnaptysBio Inc. |
ANAB |
10% | -38% |
| BeyondSpring Inc. |
BYSI |
7% | 78% |
| Zymeworks Inc. |
ZYME |
2% | 41% |
| UroGen Pharma Ltd. |
URGN |
5% | -29% |
| Biohaven Pharmaceutical Holding Company Ltd. |
BHVN |
3% | -13% |
|
|
|
|
| Ovid Therapeutics Inc. |
OVID |
1% | -71% |
| G1 Therapeutics Inc. |
GTHX |
0% | 133% |
| Athenex Inc. |
ATNX |
0% | 0% |
| Avenue Therapeutics Inc. |
ATXI |
0% | -18% |
| Mersana Therapeutics Inc. |
MRSN |
-3% | -39% |
| Aileron Therapeutics Inc. |
ALRN |
0% | -24% |
| Kala Pharmaceuticals Inc. |
KALA |
12% | 1% |
| Zai Lab Limited |
ZLAB |
-4% | -4% |
| NuCana plc |
NCNA |
0% | -36% |
| Deciphera Pharmaceuticals Inc. |
DCPH |
0% | -9% |
| Rhythm Pharmaceuticals Inc. |
RYTM |
6% | 22% |
| OptiNose Inc. |
OPTN |
0% | -68% |
| Spero Therapeutics Inc. |
SPRO |
7% | -30% |
| scPharmaceuticals Inc. |
SCPH |
1% | -44% |
| BeiGene Ltd. |
BGNE |
-2% | 2% |
| Syndax Pharmaceuticals Inc. |
SNDX |
9% | -39% |
| Hutchison China MediTech Limited |
HCM |
4% | -20% |
| Corvus Pharmaceuticals Inc. |
CRVS |
9% | 205% |
| Aeglea BioTherapeutics Inc. |
AGLE |
0% | 0% |
| Merus N.V. |
MRUS |
3% | 53% |
|
|
|
|
| Reata Pharmaceuticals Inc. |
RETA |
0% | 0% |
| Moleculin Biotech Inc. |
MBRX |
0% | -48% |
| Clearside Biomedical Inc. |
CLSD |
2% | -20% |
| Selecta Biosciences Inc. |
SELB |
0% | -27% |
| Syros Pharmaceuticals Inc. |
SYRS |
10% | -97% |
| Protagonist Therapeutics Inc. |
PTGX |
-1% | 68% |
| Novan Inc. |
NOVN |
0% | 0% |
| AC Immune SA |
ACIU |
10% | -46% |
| Myovant Sciences Ltd. |
MYOV |
0% | 0% |
| Ascendis Pharma A/S |
ASND |
2% | 9% |
| Bellerophon Therapeutics Inc. |
BLPH |
0% | 0% |
| Summit Therapeutics plc |
SMMT |
2% | 584% |
| XBiotech Inc. |
XBIT |
12% | -1% |
| KemPharm Inc. |
KMPH |
3% | 27% |
| Viking Therapeutics Inc. |
VKTX |
7% | 116% |
| Blueprint Medicines Corporation |
BPMC |
1% | -6% |
| Collegium Pharmaceutical Inc. |
COLL |
3% | -7% |
| Jaguar Health Inc. |
JAGX |
0% | 0% |
| Galapagos NV |
GLPG |
3% | -32% |
| Celyad SA |
CYAD |
0% | 0% |
|
|
|
|
| Seres Therapeutics Inc. |
MCRB |
7% | -40% |
| vTv Therapeutics Inc. |
VTVT |
0% | 0% |
| Zynerba Pharmaceuticals Inc. |
ZYNE |
0% | 0% |
| Global Blood Therapeutics Inc. |
GBT |
0% | 0% |
| Benitec Biopharma Limited |
BNTC |
0% | 0% |
| Nabriva Therapeutics plc |
NBRV |
0% | 0% |
| Aclaris Therapeutics Inc. |
ACRS |
4% | 137% |
| CytomX Therapeutics Inc. |
CTMX |
11% | -35% |
| Kura Oncology Inc. |
KURA |
0% | -39% |
| WAVE Life Sciences Ltd. |
WVE |
9% | 145% |
| Axsome Therapeutics Inc. |
AXSM |
2% | 6% |
| GlycoMimetics Inc. |
GLYC |
9% | -89% |
| Trevena Inc. |
TRVN |
0% | -72% |
| Ultragenyx Pharmaceutical Inc. |
RARE |
-1% | -12% |
| Cara Therapeutics Inc. |
CARA |
0% | -52% |
| uniQure N.V. |
QURE |
2% | 161% |
| Revance Therapeutics Inc. |
RVNC |
1% | -65% |
| Eagle Pharmaceuticals Inc. |
EGRX |
0% | 0% |
| Concert Pharmaceuticals Inc. |
CNCE |
0% | 0% |
| Galmed Pharmaceuticals Ltd. |
GLMD |
9% | 584% |
|
|
|
|
| Akebia Therapeutics Inc. |
AKBA |
0% | 53% |
| Aravive Inc. |
ARAV |
0% | -68% |
| Phibro Animal Health Corporation |
PAHC |
-2% | 81% |
| Aldeyra Therapeutics Inc. |
ALDX |
9% | 43% |
| SCYNEXIS Inc. |
SCYX |
17% | -46% |
| Agile Therapeutics Inc. |
AGRX |
0% | 0% |
| Radius Health Inc. |
RDUS |
0% | 0% |
| Ardelyx Inc. |
ARDX |
-2% | -18% |
| Amphastar Pharmaceuticals Inc. |
AMPH |
-2% | -40% |
| Minerva Neurosciences Inc |
NERV |
3% | -64% |
| Sage Therapeutics Inc. |
SAGE |
13% | -75% |
| Ocular Therapeutix Inc. |
OCUL |
3% | 92% |
| Marinus Pharmaceuticals Inc. |
MRNS |
1% | -95% |
| Catalent Inc. |
CTLT |
0% | 39% |
| Otonomy Inc. |
OTIC |
0% | 0% |
| Affimed N.V. |
AFMD |
0% | -3% |
| ProQR Therapeutics N.V. |
PRQR |
4% | 34% |
| Vascular Biogenics Ltd. |
VBLT |
0% | 0% |
| Calithera Biosciences Inc. |
CALA |
0% | 0% |
| Journey Medical Corporation |
DERM |
9% | -32% |
|
|
|
|
| Forward Pharma A/S |
FWP |
0% | 0% |
| Xenon Pharmaceuticals Inc. |
XENE |
3% | -15% |
| FibroGen Inc |
FGEN |
3% | -41% |
| Bellicum Pharmaceuticals Inc. |
BLCM |
0% | 0% |
